2026 Danilo Fliser: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	98	8849	8304	493	469	473	40544

Overview

Danilo Fliser is affiliated with Saarland University in Germany and has a significant body of research centered on medicine, with an emphasis on nephrology, cardiovascular medicine, and related fields. Their work spans subfields including nephrology, surgery, cardiology and cardiovascular medicine, endocrinology, diabetes and metabolism, and pulmonary and respiratory medicine.

The main topics covered in their research include:

Chronic Kidney Disease and Diabetes
Dialysis and Renal Disease Management
Lipoproteins and Cardiovascular Health
Diabetes Treatment and Management
Blood Pressure and Hypertension Studies
Electrolyte and hormonal disorders
Potassium and Related Disorders

Frequent publication venues where Danilo Fliser has contributed include:

Nephrology Dialysis Transplantation
European Heart Journal
Kidney International Reports
Journal of the American Society of Nephrology
Clinical Kidney Journal

Among recent publications are:

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, 2021, European Heart Journal
Cardiovascular Disease in Chronic Kidney Disease, 2021, Circulation
Chronic kidney disease and the global public health agenda: an international consensus, 2024, Nature Reviews Nephrology
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, 2021, European Journal of Preventive Cardiology
WNT-β-catenin signalling - a versatile player in kidney injury and repair, 2020, Nature Reviews Nephrology

Danilo Fliser has collaborated extensively with several coauthors throughout their career, including:

Thimoteus Speer
Ziad A. Massy
Stefan Schunk
Alberto Ortíz
Christoph Wanner

Best Publications

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Frank L J Visseren;François Mach;Yvo M Smulders;David Carballo

3938
Citations
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.

Joachim Jankowski;Jürgen Floege;Danilo Fliser;Michael Böhm

1113
Citations
Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

Danilo Fliser;Barbara Kollerits;Ulrich Neyer;Donna P. Ankerst

857
Citations
Erythropoietin regulates endothelial progenitor cells.

Ferdinand H. Bahlmann;Kirsten de Groot;Jens-Michael Spandau;Aimee L. Landry

739
Citations
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy

Danilo Fliser;Maurice Laville;Adrian Covic

654
Citations
SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset

Adam M. Zawada;Kyrill S. Rogacev;Björn Rotter;Peter Winter

634
Citations
Simvastatin Versus Ezetimibe Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans

Ulf Landmesser;Ferdinand Bahlmann;Maja Mueller;Stephan Spiekermann

603
Citations
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

David M. Good;Petra Zürbig;Àngel Argilés;Hartwig W. Bauer

599
Citations
CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.

Kyrill S. Rogacev;Bodo Cremers;Adam M. Zawada;Sarah Seiler

587
Citations
Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation

Danilo Fliser;Konrad Buchholz;Hermann Haller

569
Citations
Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans

Jan T. Kielstein;Burcu Impraim;Solveig Simmel;Stefanie M. Bode-Böger

564
Citations
Serum cystatin C concentration as a marker of renal dysfunction in the elderly.

Danilo Fliser;Eberhard Ritz

536
Citations
Marked Increase of Asymmetric Dimethylarginine in Patients with Incipient Primary Chronic Renal Disease

Jan T. Kielstein;Rainer H. Böger;Stefanie M. Bode-Böger;Jürgen C. Frölich

516
Citations
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

Alberto Ortiz;Adrian Covic;Danilo Fliser;Denis Fouque

490
Citations
Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

Sajoscha A. Sorrentino;Ferdinand H. Bahlmann;Christian Besler;Maja Müller

462
Citations
Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease Study

Danilo Fliser;Florian Kronenberg;Jan T. Kielstein;Christian Morath

455
Citations
Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease: The Mild and Moderate Kidney Disease Study

Bjoern Becker;Florian Kronenberg;Jan T Kielstein;Hermann Haller

449
Citations
INSULIN RESISTANCE AND HYPERINSULINEMIA ARE ALREADY PRESENT IN PATIENTS WITH INCIPIENT RENAL DISEASE

Danilo Fliser;Giovanni Pacini;Giovanni Pacini;Renate Engelleiter;Renate Engelleiter;Alexandra Kautzky-Willer;Alexandra Kautzky-Willer

443
Citations
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis

Jan T. Kielstein;Shelley R. Salpeter;Stefanie M. Bode-Boeger;John P. Cooke

400
Citations
Prometheus--a new extracorporeal system for the treatment of liver failure.

Kinan Rifai;Thomas Ernst;Ulrich Kretschmer;Matthias J Bahr

386
Citations

Frequent Co-Authors

Hermann Haller Hannover Medical School

Jan T. Kielstein Hannover Medical School

Carmine Zoccali Biogem

Ziad A. Massy Versailles Saint-Quentin-en-Yvelines University

Winfried März Medical University of Graz

Alberto Ortiz Autonomous University of Madrid

Adrian Covic Grigore T. Popa University of Medicine and Pharmacy

Gérard M. London Grenoble Alpes University

Raymond Vanholder Ghent University

Francesca Mallamaci National Research Council (CNR)

External Links

Personal website of Danilo Fliser

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring online healthcare degrees can open up flexible and rewarding career opportunities, especially for those seeking alternative pathways to medical professions in the USA. If you’re a registered nurse looking to advance your credentials without the demands of in-person training, consider pursuing an rn to bsn without clinicals program. These options let you earn your degree fully online, saving time and fitting into busy schedules.

For those aiming higher, a Doctor of Nursing Practice (DNP) can be achieved efficiently with the shortest dnp program online or by choosing among leading dnp online programs. These programs blend academic rigor with streamlined formats, making advanced leadership roles within nursing more accessible.

Entry-level healthcare roles can also be reached quickly. Aspiring practical nurses may benefit from a 6 month lpn program online, allowing for a fast track into the workforce. No matter your goals, online degrees offer flexible ways to progress in healthcare while balancing other commitments.